Breaking
● GLP-1 trial shows 34% reduction in cardiovascular events over 5 years ● Senolytics drug enters Phase III — first human trial results expected Q1 2027 ● FDA fast-tracks CRISPR base-editing therapy for sickle cell disease ● Longevity biotech index up 12% YTD as institutional capital accelerates ● AI diagnostic platform achieves 97.2% accuracy in early-stage pancreatic cancer detection ● Harvard study links CGM use to 23% lower all-cause mortality in non-diabetics
Impact Health Magazine
Home
The Science

The Biology of a Longer, Better Life

Peer-reviewed research, clinical breakthroughs, and the science powering the next generation of human performance

142

Peer-reviewed studies cited this quarter

38

Contributing physicians and researchers

4

Core science disciplines covered

Featured Articles
The GLP-1 Revolution: How Weight-Loss Drugs Are Rewriting Metabolic Medicine
Metabolic Health

The GLP-1 Revolution: How Weight-Loss Drugs Are Rewriting Metabolic Medicine

Eli Lilly's Zepbound and Novo Nordisk's Ozempic have done more than reshape bodies — they've reshaped an entire industry. We examine the science, the investment thesis, and what comes next.

Dr. Marcus Hale·September 2, 2026·12 min read
Telomere Testing and the New Science of Biological Age Reversal
Longevity

Telomere Testing and the New Science of Biological Age Reversal

Pioneering research suggests targeted protocols can reverse biological age by an average of 3.2 years. We speak with the scientists leading the charge.

Dr. James Whitfield·August 28, 2026·9 min read
Inside the Neuroplasticity Protocol Used by Fortune 500 CEOs
Mental Performance

Inside the Neuroplasticity Protocol Used by Fortune 500 CEOs

From transcranial magnetic stimulation to precision sleep architecture, the cognitive optimization stack favored by the world's most demanding executives.

Dr. Priya Nair·August 20, 2026·10 min read